NDSIB
RPRX icon

North Dakota State Investment Board’s Royalty Pharma RPRX Stock Holding History

North Dakota State Investment Board’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Buy
11,431
+59
+0.5% +$3.07K 0.03% 438
2026
Q1 		$546K Sell
11,372
-1,978
-15% -$86.6K 0.02% 442
2025
Q4 		$516K Buy
+13,350
New +$509K 0.02% 514

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

North Dakota State Investment Board's RPRX Position: Q2 2026 in Review

North Dakota State Investment Board increased its Royalty Pharma (RPRX) stake by 0.52% in Q2 2026, buying an estimated $3.07K and bringing the position to 11,431 shares worth $641K. The position accounts for 0.03% of the portfolio, ranked #438.

North Dakota State Investment Board first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • North Dakota State Investment Board held 11,431 shares of Royalty Pharma worth $641K as of Q2 2026.
  • North Dakota State Investment Board bought 59 Royalty Pharma shares in Q2 2026, an estimated $3.07K.
  • Royalty Pharma made up 0.03% of North Dakota State Investment Board's portfolio in Q2 2026, its #438 holding.
  • North Dakota State Investment Board first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.